American Journal of Obstetrics and Gynecology
SupplementPreparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns
Section snippets
Antiviral treatment and chemoprophylaxis
Issues related to influenza treatment were considered, including the severity of disease in pregnant women and benefits and risks of treatment to the mother and fetus. Consistent with data from previous influenza pandemics and seasonal influenza,2 pregnant women were at increased risk for 2009 H1N1-associated morbidity and death; pregnant women had a 4-fold increased risk of hospitalization4 and accounted for a disproportionate number of deaths.3 During the 2009-2010 season, the CDC recommended
Vaccination
The Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend the administration of inactivated influenza vaccine for all women who are pregnant during the influenza season, regardless of pregnancy trimester.30, 31 In influenza pandemic situations and periods of vaccine shortage, pregnant women are included in the highest priority group for influenza vaccination because of their increased risk for influenza-associated morbidity and death.
Intrapartum and newborn infant (including infection control) issues
Issues that are related to vertical transmission, hospital infection control, discharge advice, and use of antiviral medications while breastfeeding were discussed. Data are limited on vertical transmission of seasonal or pandemic influenza viruses; vertical transmission has been suggested to occur with maternal illness (usually severe), although it appears to be rare.75, 76, 77, 78 Asymptomatic newborn infants who are born to mothers who are symptomatic or who have recovered from suspected or
Nonpharmaceutical interventions and health care planning during a pandemic
Before the 2009 H1N1 pandemic, the CDC, in collaboration with other federal agencies and public health partners, developed interim guidance on the use of nonpharmaceutical interventions in the event of a pandemic.83 This guidance was designed to mitigate an influenza pandemic and included measures (eg, school dismissals, social distancing) other than vaccination and antiviral treatment. During the 2009 H1N1 pandemic, CDC-issued guidance on prevention emphasized universal adherence to good
Communication
Despite the efforts of public health agencies and professional organizations to promote and communicate information about influenza, influenza vaccination coverage among pregnant women has historically been low,33 and many pregnant women with suspected 2009 H1N1 did not receive recommended antiviral treatment in a timely manner.3, 4 Improved outreach, education, and communication efforts are needed, including tailored strategies for different population subgroups of pregnant women.
Comment
Pregnant women and their newborn infants are at increased risk of severe influenza illness. Although the 2009 H1N1 pandemic emphasized the importance of special considerations for these populations in a pandemic situation, these populations are also at increased risk for severe complications with seasonal influenza. Regardless of influenza vaccination status, women who are pregnant or <2 weeks after delivery with suspected influenza should receive early antiviral treatment. Treatment of fever
Acknowledgments
Members of the Pandemic Influenza and Pregnancy Working Group include Sharon Alexander, Robert Wood Johnson University Hospital, New Brunswick, NJ; Kevin Ault, Emory University, Atlanta, GA; Hilary Babcock, Washington University School of Medicine, St. Louis, MO; Carol Baker, Baylor College of Medicine, Houston, TX; Niranjan Bhat, Johns Hopkins Children's Center, Baltimore, MD; Carolyn Bridges, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and
References (85)
- et al.
H1N1 2009 influenza virus infection during pregnancy in the USA
Lancet
(2009) - et al.
Association of maternal fever during labor with neonatal and infant morbidity and mortality
Obstet Gynecol
(2001) - et al.
Acetaminophen use during pregnancy: effects on risk for congenital abnormalities
Am J Obstet Gynecol
(2008) - et al.
Influenza vaccination of recommended adult populations, US, 1989-2005
Vaccine
(2008) - et al.
Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008
J Pediatr
(2010) - et al.
A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome
Am J Obstet Gynecol
(1981) - et al.
Safety of influenza vaccination during pregnancy
Am J Obstet Gynecol
(2005) - et al.
Safety of influenza vaccination during pregnancy
Am J Obstet Gynecol
(2009) - et al.
Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009
Am J Obstet Gynecol
(2011) - et al.
The obstetrician-gynecologist's role in vaccine-preventable diseases and immunization
Obstet Gynecol
(2000)
Vaccination and perinatal infection prevention practices among obstetrician-gynecologists
Obstet Gynecol
Obstetrician-gynecologists' practices and perceived knowledge regarding immunization
Am J Prev Med
Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review
Am J Prev Med
Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers
Am J Obstet Gynecol
Impact of patient education on knowledge of influenza and vaccine recommendations among pregnant women
J Obstet Gynaecol Can
H5N1 infection of the respiratory tract and beyond: a molecular pathology study
Lancet
Oseltamivir and breastfeeding
Int J Infect Dis
Emergence of a novel swine-origin influenza A (H1N1) virus in humans
N Engl J Med
Pandemic influenza and pregnant women
Emerg Infect Dis
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States
JAMA
Interim guidance: considerations regarding 2009 H1N1 influenza in intrapartum and postpartum hospital settings
Updated interim recommendations for obstetric health care providers related to use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season
Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
MMWR Recomm Rep
Pandemic influenza and pregnant women: Summary of a meeting of experts
Am J Public Health
Severe 2009 H1N1 influenza in pregnant and postpartum women in California
N Engl J Med
FluView: a weekly influenza surveillance report prepared by the Influenza Division
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays
Antimicrob Agents Chemother
Comprehensive assessment of 2009 influenza A (H1N1) virus drug susceptibility in vitro
Antivir Ther
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications
Obstet Gynecol
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women
CMAJ
Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus: United States, 2009
MMWR Morb Mortal Wkly Rep
2009 pandemic influenza A (H1N1) virus infection in postpartum women in California
Am J Obstet Gynecol
Review: hyperthermia and fever during pregnancy
Birth Defects Res A Clin Mol Teratol
Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis
Epidemiology
Aspirin and reproductive outcomes
Obstet Gynecol Surv
TERIS, The Teratogen Information System
Non-genetic risk factors for gastroschisis
Am J Med Genet C Semin Med Genet
Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study
Obstet Gynecol
Prenatal exposure to acetaminophen and asthma in children
Obstet Gynecol
Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: a birth cohort study
Int J Epidemiol
Paracetamol use in early life and asthma: prospective birth cohort study
BMJ
Cited by (64)
Pregnancy, infection, and epigenetic regulation: A complex scenario
2023, Biochimica et Biophysica Acta - Molecular Basis of DiseaseHereditary angioedema and COVID-19 during pregnancy: Two case reports
2023, Journal of Allergy and Clinical Immunology: In PracticeCoronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know
2020, American Journal of Obstetrics and GynecologyCitation Excerpt :Given the current lack of information, it seems reasonable to assume that a newborn born to a mother with COVID-19 at delivery could possibly be infected, either in utero or perinatally, and thus should be placed in isolation to avoid exposure to other newborns. Although the ideal setting for a healthy infant is within a healthy mother’s room, temporary separation of an ill mother and her infant, as was recommended during pandemic H1N1,51 seems prudent. Whether COVID-19 can be transmitted through breastmilk is unknown.
Cohort of pregnant and postpartum women with COVID-19. Comparative analysis between two pandemic waves
2022, Medicina (Argentina)International Registry of Coronavirus Exposure in Pregnancy (IRCEP): Cohort Description and Methodological Considerations
2022, American Journal of Epidemiology
Reprints not available from the authors.
Authorship and contribution to the article is limited to the authors indicated. There was no outside funding or technical assistance with the production of this article.
Conflict of Interest: none.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Publication of this article was supported by the Centers for Disease Control and Prevention and the Association of Maternal and Child Health Programs.